4 Insights on decentralized trials for biotechs
The COVID-19 pandemic accelerated the adoption of decentralized clinical trials (DCTs) by biopharma companies. The clinician-patient relationship will always be key to clinical trials, but decentralized aspects such as direct-to-patient shipments and telehealth are here to stay. Here are four things we have learned about DCTs that biotech companies can consider when designing a decentralized or hybrid trial.
Related Insights
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Podcast
Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Blog
Decentralized Trials: Considerations for Building a New Patient-Centric Model
May 13, 2021
Article
How a joined-up development strategy pays off for early-stage biotechs
May 19, 2021
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Blog
Scientific Advances: Catalyst for Biotech Investment and Innovation in Clinical Development
Mar 12, 2024
Blog
Investor-ready evidence planning: Why a robust strategy matters to funders
Dec 8, 2025
Podcast
Decentrally Speaking | Episode 2: The Shifting Roles of Pharmaceutical Depots within a Decentralized Trial Environment
May 9, 2022
Video
Part 2: Practically Speaking: Driving Clinical Transformation
Feb 9, 2022
Article
How biotechs can strengthen their value story with advanced analytics
Feb 15, 2022
Article
Getting to ‘No’ fast is more important when you are small
Mar 4, 2022
Related Insights
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Podcast
Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Blog
Decentralized Trials: Considerations for Building a New Patient-Centric Model
May 13, 2021
Article
How a joined-up development strategy pays off for early-stage biotechs
May 19, 2021
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Blog
Scientific Advances: Catalyst for Biotech Investment and Innovation in Clinical Development
Mar 12, 2024
Blog
Investor-ready evidence planning: Why a robust strategy matters to funders
Dec 8, 2025
Podcast
Decentrally Speaking | Episode 2: The Shifting Roles of Pharmaceutical Depots within a Decentralized Trial Environment
May 9, 2022
Video
Part 2: Practically Speaking: Driving Clinical Transformation
Feb 9, 2022
Article
How biotechs can strengthen their value story with advanced analytics
Feb 15, 2022
Article
Getting to ‘No’ fast is more important when you are small
Mar 4, 2022